One of the most intriguing developments in synthetic biology in 2026 has revived an old question: where exactly is the boundary between a sophisticated chemical system and life? Researchers at the University of Minnesota have developed SpudCell, a synthetic cell-like system assembled from defined, purified, non-living components that can perform several of the fundamental processes associated with natural cells.
The project was developed by teams led by Kate Adamala and Aaron Engelhart. The results were presented in the summer of 2026, with the University of Minnesota describing SpudCell as the first bottom-up synthetic cell system made from non-living chemical components to demonstrate a complete cell cycle.
That description, however, needs to be interpreted carefully. The researchers are not claiming to have created a completely autonomous living organism. SpudCell is an engineered system and remains far simpler and more dependent on laboratory support than even the simplest natural cells.
Its abilities are nevertheless remarkable. SpudCell can acquire resources, grow, replicate its DNA and divide into daughter structures. Bringing these processes together within the same chemically defined system is the key scientific achievement.
Inside its lipid membrane is a genome of approximately 90,000 base pairs. The genome is divided among seven DNA plasmids rather than being organised as a single chromosome. This modular design allows different cellular functions to be modified independently.
The genome is unusually small. Researchers have previously estimated that a minimal living cell might require a genome of around 113,000 base pairs, while SpudCell operates with approximately 90,000. A human genome, by comparison, contains roughly three billion base pairs.
SpudCell also contains a defined protein-production system based on 36 purified enzymes, together with ribosomes and other molecular components. Because the ingredients and their concentrations are known, researchers can examine the system in considerably greater detail than would be possible with an ordinary living cell.
The major advance is not that scientists can reproduce an individual cellular process. Researchers have been able to reconstruct separate biological functions for years. The difficult part has been connecting them so that one synthetic system can proceed through growth, genome replication and division.
SpudCell grows in an unusual way. Rather than manufacturing all of its own nutrients through a complex metabolism, it receives resources from small feeder liposomes. These provide membrane lipids as well as molecular machinery and nutrients required for continued operation.
That approach dramatically reduces the genetic complexity required for the synthetic cell, but it also reveals one of SpudCell’s major limitations: it is not self-sufficient.
Natural cells possess metabolic networks involving large numbers of genes and enzymes that allow them to produce many of their own components. SpudCell instead depends on externally supplied material and carefully controlled laboratory conditions.
One particularly important limitation is that it cannot manufacture its own ribosomes. Ribosomes are the molecular machines that translate genetic instructions into proteins and are essential to cellular activity.
Without the ability to reproduce all of its own molecular machinery, SpudCell remains dependent on components supplied by researchers. It therefore cannot simply be placed into an ordinary environment and continue functioning indefinitely like an autonomous organism.
This is why the question “Is SpudCell alive?” does not have a simple answer. Science has no single universally accepted definition of life. Autonomous metabolism, reproduction, heredity and the ability to undergo evolution are among the characteristics commonly considered important.
SpudCell nevertheless demonstrates something particularly interesting – selection and competition. Researchers introduced a genetic modification that increased production of a protein involved in feeding and growth.
Cells carrying that modification grew faster and produced more offspring. After five generations, the faster-growing variant had outcompeted the original population. Under conditions of limited nutrients, its advantage became even stronger.
This demonstration of selection in a completely synthetic chemical system is scientifically significant because it establishes a link between genetic information, cellular behaviour and reproductive success.
But some of the possible applications already being discussed – treating cancer, manufacturing medicines inside the human body, cleaning polluted environments or operating in space – should not be confused with abilities SpudCell possesses today.
They are potential future applications of much more advanced synthetic cells. SpudCell itself is not currently a medical treatment and has not been demonstrated as a therapy capable of treating cancer or replacing chemotherapy.
The longer-term concept is nevertheless fascinating. If researchers eventually develop reliable and programmable synthetic cells, they could theoretically be engineered to perform highly specific tasks.
One possibility would be producing a particular molecule only when it is needed. Another could involve delivering therapeutic substances directly to particular tissues, potentially reducing exposure of healthy cells.
Cancer research is one area where such technology could eventually become interesting. Future synthetic cells might theoretically be programmed to detect characteristics of the environment surrounding a tumour and produce a therapeutic molecule at that location.
But claims that synthetic cells could soon eliminate the need for chemotherapy would be premature. Turning a laboratory system such as SpudCell into a safe treatment for humans would require major advances, extensive testing and regulatory evaluation.
Potential applications also extend beyond medicine. Synthetic cells could eventually function as tiny biological factories producing chemicals and materials through biological processes rather than relying on conventional petroleum-based manufacturing.
Environmental applications are another possibility. Engineered systems might eventually be designed to detect or break down particular pollutants, process waste or participate in carbon capture.
This is also where one of the major safety questions appears. What happens if a future self-replicating synthetic system is released outside the laboratory?
The ability to reproduce is simultaneously one of the most impressive characteristics of synthetic cells and one of the reasons that increasingly autonomous versions would require strong biosafety mechanisms.
Future systems could potentially incorporate biological containment mechanisms – for example, dependence on artificial nutrients that do not exist naturally or genetic safeguards designed to prevent unrestricted replication.
Evolution presents another challenge. Once a system is capable of reproduction and genetic variants with certain advantages reproduce more successfully, characteristics not originally intended by its designers could potentially emerge over multiple generations.
That does not mean the current SpudCell is an organism capable of escaping from a laboratory and spreading uncontrollably. The existing system remains heavily dependent on specialised conditions and externally supplied molecular components.
For now, that dependence provides a substantial barrier. But if future generations of synthetic cells become progressively more autonomous, questions of containment, predictability and control will become increasingly important.
There is another important scientific qualification. The SpudCell work was initially released as a preprint. That makes the research available for scientific examination and replication, but a preprint should not automatically be treated in the same way as a final paper that has completed formal peer review.
The researchers are also attempting to make the technology an open engineering platform. Through the Biotic initiative, protocols and technical infrastructure are being developed so that other laboratories can reproduce, modify and improve synthetic-cell systems.
That could accelerate progress considerably, but it also highlights the importance of developing biosafety standards alongside the technology.
The real significance of SpudCell is therefore not that scientists can confidently say they have “created life.” The achievement is that researchers have connected several fundamental cellular processes within a chemically defined system assembled from non-living components.
A natural cell is the product of billions of years of evolution and contains an extraordinarily complicated network of interacting processes. SpudCell is dramatically simpler.
Its simplicity, however, may be precisely what makes it scientifically valuable. Researchers know which components were placed inside it and can modify those components individually to investigate which mechanisms are truly necessary for cell-like behaviour.
The next major challenge will be increasing autonomy – improving metabolism, stabilising inheritance of the genome and enabling the system to manufacture more of its own molecular machinery.
If scientists eventually achieve those goals, synthetic cells could become an entirely new category of biotechnology: not merely existing organisms whose genes have been modified, but cellular systems assembled from defined components and programmed for specific purposes.
That could eventually open new possibilities in medicine, manufacturing, environmental technology and fundamental research into the nature of life itself.
But as an artificial cell becomes progressively more similar to a natural one, another question becomes increasingly important: not only what can scientists program it to do, but how can they ensure that it continues to do only what it was designed to do?
